Ameriprise Financial, Inc. 13D and 13G filings for Eiger BioPharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-10 2:14 pm Sale |
2024-04-30 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
AMERIPRISE FINANCIAL INC AMP |
0 0.000% |
-7,505,539 (Position Closed) |
Filing |
| 2024-02-14 10:55 am Purchase |
2023-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
AMERIPRISE FINANCIAL INC AMP |
7,505,539 16.910% |
7,237,908 (+2704.44%) |
Filing |
| 2023-04-10 1:37 pm Purchase |
2023-02-28 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
AMERIPRISE FINANCIAL INC AMP |
267,631 18.220% |
86,139 (+47.46%) |
Filing |
| 2023-01-10 12:12 pm Sale |
2022-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
AMERIPRISE FINANCIAL INC AMP |
181,492 12.350% |
-71,512 (-28.27%) |
Filing |
| 2022-05-11 3:01 pm Purchase |
2022-05-06 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
AMERIPRISE FINANCIAL INC AMP |
253,004 17.560% |
18,043 (+7.68%) |
Filing |
| 2022-01-21 3:25 pm Purchase |
2021-12-27 | 13D | Eiger BioPharmaceuticals, Inc. EIGR |
AMERIPRISE FINANCIAL INC AMP |
234,961 20.750% |
39,639 (+20.29%) |
Filing |
| 2021-09-10 10:31 am Purchase |
2021-08-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
AMERIPRISE FINANCIAL INC AMP |
195,322 17.260% |
64,594 (+49.41%) |
Filing |
| 2021-01-11 11:46 am Purchase |
2020-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
AMERIPRISE FINANCIAL INC AMP |
130,728 12.060% |
130,728 (New Position) |
Filing |